Prognostic factors for overall survival (OS) in metastatic melanoma (MM) patients (pts) treated with immune checkpoint inhibitors: A single institution study of 696 pts.

被引：2
|
作者：
McKean, Meredith Ann
Haydu, Lauren Elaine
Ma, Junsheng
Bassett, Roland L.
Hwu, Wen-Jen
Patel, Sapna Pradyuman
Diab, Adi
Glitza, Isabella Claudia
Tawbi, Hussein Abdul-Hassan
Wong, Michael K.
McQuade, Jennifer Leigh
Hwu, Patrick
Davies, Michael A.
Amaria, Rodabe Navroze
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.9574
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9574
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Real-world prognostic model for overall survival (OS) in patients (pts) with advanced urothelial cancer (aUC) treated with immune checkpoint inhibitors (ICI)
    Khaki, Ali Raza
    Diamantopoulos, Leonidas Nikolaos
    Miller, Natalie J.
    Bilen, Mehmet Asim
    Santos, Victor Sacristan
    Morales-Barrera, Rafael
    Devitt, Michael Edward
    Nelson, Ariel Ann
    Shreck, Evan
    Assi, Hussein
    Zakopoulou, Roubini
    Rodriguez-Vida, Alejo
    Lythgoe, Mark
    Drakaki, Alexandra
    Joshi, Monika
    Velho, Pedro Isaacsson
    Alonso, Lucia
    Galsky, Matt D.
    Sonpavde, Guru
    Grivas, Petros
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [2] Immune Prognostic Index as a predictor of survival in patients with metastatic melanoma treated with immune checkpoint inhibitors
    Stukalin, Igor
    Suo, Aleksi
    Vallerand, Isabelle A.
    Lewinson, Ryan
    Heng, Daniel Y. C.
    Bebb, D. Gwyn
    Morris, Don G.
    Cheng, Tina
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB100 - AB100
  • [3] Overall Survival (OS) and New Patterns of Response in Patients (Pts) With Advanced Melanoma Treated With Ipilimumab
    O'Day, Steven
    Ibrahim, Ramy
    De Pril, Veerle
    Maio, Michele
    Sileni, Vanna Chiarion
    Gajewski, Thomas F.
    Pehamberger, Hubert
    Bondarenko, Igor N.
    Queirolo, Paola
    Lundgren, Lotta
    Mikhailov, Sergey
    Roman, Laslo
    Verschraegen, Claire
    Hoos, Axel
    Humphrey, Rachel
    Wolchok, Jedd
    [J]. JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 937 - 938
  • [4] Clinical factors and overall survival (OS) associated with patterns of metastases (mets) in melanoma patients (pts)
    da Silva, I. Pires
    Lo, S.
    Carlino, M. S.
    Scolyer, R. A.
    Menzies, A. M.
    Long, G. V.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [5] Single-institutional analysis of clinicopathologic features and overall survival (OS) in melanoma patients (pts).
    Wang, Ding
    Wang, Jonathan
    Krajenta, Richard
    Zhu, Liping
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] A nomogram based prognostic score to predict overall survival (OS) in recurrent-metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pts) treated with immune checkpoint inhibitors (ICI)
    Mousa, L.
    Issa, M.
    Klamer, B.
    Pan, J.
    Old, M.
    Kang, S.
    Agrawal, A.
    Ozer, E.
    Carrau, R.
    Bhateja, P.
    Rupert, R.
    Jhawar, S.
    Mitchell, D.
    Gamez, M.
    Rocco, J.
    Blakaj, D.
    Bonomi, M. R.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [7] Impact of immune-checkpoint inhibitors (ICPIs) as treatment of patients (pts) with metastatic primary uveal melanoma (UM): Results of a single-institution database
    Lee, C. L.
    Gullo, G.
    Horgan, N.
    Smith, D.
    Moran, M.
    Crown, J. P.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [8] Overall survival (OS) and prognostic factors (PF) of patients (pts) with metastatic solid tumors admitted in intensive care unit (ICU).
    Hautecloque-Raysz, Segolene
    Thananayagam, Marie Albert
    Martignene, Niels
    Le Deley, Marie-Cecile
    Penel, Nicolas
    Carnot, Aurelien
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Combination of brain radiotherapy (RT) and immunotherapy (IT) in a single Institution cohort of patients (pts) with metastatic melanoma (MM)
    Galli, G.
    Cavalieri, S.
    Di Guardo, L.
    Cimminiello, C.
    Corti, F.
    Nichetti, F.
    Garcia, M.
    Tana, S.
    Fallai, C.
    de Braud, F.
    Platania, M.
    Del Vecchio, M.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [10] Dynamics of clinical biomarkers as predictors of immunotherapy (IT) benefit in metastatic melanoma (MM) patients (pts) treated in reference institution
    Hernando, A.
    Dienstmann, R.
    Ortiz Velez, C.
    Villacampa, G.
    Ros Montana, F. J.
    Grau Bejar, J. F.
    Garcia-Alvarez, A.
    Nuciforo, P. G.
    Gros, A.
    Garcia-Patos, V.
    Bodet, D.
    Ferrer Fabrega, B.
    Recio, J.
    Munoz-Couselo, E.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
12345